{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:47:12Z","timestamp":1793677632193,"version":"4.5.1"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270736"],"award-info":[{"award-number":["82270736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02303-7","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T04:47:46Z","timestamp":1752814066000},"page":"3747-3762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP"],"prefix":"10.1007","volume":"48","author":[{"given":"Mustafa","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Geng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Potempa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"4","key":"2303_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.52.4.561","volume":"52","author":"WS Tillett","year":"1930","unstructured":"Tillett, W.S., and T. Francis. 1930. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. Journal of Experimental Medicine 52 (4): 561\u2013571.","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"2303_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.73.2.173","volume":"73","author":"TJ Abernethy","year":"1941","unstructured":"Abernethy, T.J., and O.T. Avery. 1941. The occurrence during acute infections of a protein not normally present in the blood\u202f: I distribution of the reactive protein in Patients\u2019 Sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus. The Journal of Experimental Medicine 73 (2): 173\u201382.","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"2303_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0969-2126(99)80023-9","volume":"7","author":"D Thompson","year":"1999","unstructured":"Thompson, D., M.B. Pepys, and S.P. Wood. 1999. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7 (2): 169\u2013177.","journal-title":"Structure"},{"issue":"20","key":"2303_CR4","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1021\/bi00135a023","volume":"31","author":"RA Schwalbe","year":"1992","unstructured":"Schwalbe, R.A., B. Dahlback, J.E. Coe, and G.L. Nelsestuen. 1992. Pentraxin family of proteins interact specifically with phosphorylcholine and\/or phosphorylethanolamine. Biochemistry 31 (20): 4907\u20134915.","journal-title":"Biochemistry"},{"issue":"6","key":"2303_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4049\/jimmunol.2200831","volume":"210","author":"SR Ji","year":"2023","unstructured":"Ji, S.R., S.H. Zhang, Y. Chang, H.Y. Li, M.Y. Wang, J.M. Lv, et al. 2023. C-reactive protein: The most familiar stranger. The Journal of Immunology 210 (6): 699\u2013707.","journal-title":"The Journal of Immunology"},{"key":"2303_CR6","doi-asserted-by":"publisher","first-page":"1564607","DOI":"10.3389\/fimmu.2025.1564607","volume":"16","author":"M Potempa","year":"2025","unstructured":"Potempa, M., P.C. Hart, I.M. Rajab, and L.A. Potempa. 2025. Redefining CRP in tissue injury and repair: More than an acute pro-inflammatory mediator. Frontiers in Immunology 16: 1564607.","journal-title":"Frontiers in Immunology"},{"issue":"3\u20134","key":"2303_CR7","first-page":"221","volume":"11","author":"AJ Szalai","year":"2004","unstructured":"Szalai, A.J. 2004. C-reactive protein (CRP) and autoimmune disease: Facts and conjectures. Clinical and Developmental Immunology 11 (3\u20134): 221\u2013226.","journal-title":"Clinical and Developmental Immunology"},{"issue":"11","key":"2303_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/qjmed\/hcg134","volume":"96","author":"GM Hirschfield","year":"2003","unstructured":"Hirschfield, G.M., and M.B. Pepys. 2003. C-reactive protein and cardiovascular disease: New insights from an old molecule. QJM 96 (11): 793\u2013807.","journal-title":"QJM"},{"key":"2303_CR9","doi-asserted-by":"publisher","first-page":"595835","DOI":"10.3389\/fimmu.2020.595835","volume":"11","author":"PC Hart","year":"2020","unstructured":"Hart, P.C., I.M. Rajab, M. Alebraheem, and L.A. Potempa. 2020. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Frontiers in Immunology 11: 595835.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"2303_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/cr.2014.7","volume":"24","author":"MY Wang","year":"2014","unstructured":"Wang, M.Y., H.H. Zhou, S.C. Zhang, F. Hui, W. Zhu, H.X. Su, et al. 2014. Recurrent mutations at C-reactive protein gene promoter SNP position -286 in human cancers. Cell Research 24 (4): 505\u2013508.","journal-title":"Cell Research"},{"issue":"24","key":"2303_CR11","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1158\/0008-5472.CAN-24-0253","volume":"84","author":"JR Feng","year":"2024","unstructured":"Feng, J.R., X. Li, C. Han, Y. Chang, Y. Fu, G.C. Feng, et al. 2024. C-Reactive Protein Induces Immunosuppression by Activating Fc\u03b3R2B in Pulmonary Macrophages to Promote Lung Metastasis. Cancer Research 84 (24): 4184\u20134198.","journal-title":"Cancer Research"},{"issue":"24","key":"2303_CR12","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.3390\/jcm10245837","volume":"10","author":"H Enocsson","year":"2021","unstructured":"Enocsson, H., J. Karlsson, H.Y. Li, Y. Wu, I. Kushner, J. Wettero, et al. 2021. The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus. Journal of Clinical Medicine 10 (24): 5837.","journal-title":"Journal of Clinical Medicine"},{"issue":"14","key":"2303_CR13","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s11434-012-5591-3","volume":"58","author":"X Ma","year":"2012","unstructured":"Ma, X., S.-R. Ji, and Y. Wu. 2012. Regulated conformation changes in C-reactive protein orchestrate its role in atherogenesis. Chinese Science Bulletin 58 (14): 1642\u20131649.","journal-title":"Chinese Science Bulletin"},{"key":"2303_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cyto.2016.08.021","volume":"88","author":"S Schulz","year":"2016","unstructured":"Schulz, S., H. Ludike, M. Lierath, A. Schlitt, K. Werdan, B. Hofmann, et al. 2016. C-reactive protein levels and genetic variants of CRP as prognostic markers for combined cardiovascular endpoint (cardiovascular death, death from stroke, myocardial infarction, and stroke\/TIA). Cytokine 88: 71\u201376.","journal-title":"Cytokine"},{"key":"2303_CR15","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3389\/fimmu.2018.01302","volume":"9","author":"YY Luan","year":"2018","unstructured":"Luan, Y.Y., and Y.M. Yao. 2018. The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Frontiers in Immunology 9: 1302.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"2303_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/cvr\/cvy181","volume":"115","author":"HY Li","year":"2019","unstructured":"Li, H.Y., X.L. Liu, Y.T. Liu, Z.K. Jia, J.G. Filep, L.A. Potempa, et al. 2019. Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein. Cardiovascular Research 115 (2): 440\u2013452.","journal-title":"Cardiovascular Research"},{"issue":"1","key":"2303_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.52601\/bpr.2022.210032","volume":"8","author":"L Houfang","year":"2022","unstructured":"Houfang, L., Z. Shuyi, S. Yunpeng, and L. Cong. 2022. Biochemical and biophysical characterization of pathological aggregation of amyloid proteins. Biophysics Reports 8 (1): 42\u201354.","journal-title":"Biophysics Reports"},{"issue":"3","key":"2303_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.52601\/bpr.2022.220013","volume":"8","author":"Y Jiawen","year":"2022","unstructured":"Jiawen, Y., S. Sen-Fang, and L. Zheng. 2022. Brain structure and structural basis of neurodegenerative diseases. Biophysics Reports 8 (3): 170\u2013181.","journal-title":"Biophysics Reports"},{"issue":"4","key":"2303_CR19","first-page":"213","volume":"10","author":"S Jin","year":"2024","unstructured":"Jin, S., J. Wang, and Y. He. 2024. The brain network hub degeneration in Alzheimer\u2019s disease. Biophysics Reports 10 (4): 213\u2013229.","journal-title":"Biophysics Reports"},{"issue":"11","key":"2303_CR20","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3899\/jrheum.080262","volume":"35","author":"PB Shih","year":"2008","unstructured":"Shih, P.B., S. Manzi, P. Shaw, M. Kenney, A.H. Kao, F. Bontempo, et al. 2008. Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. Journal of Rheumatology 35 (11): 2171\u20132178.","journal-title":"Journal of Rheumatology"},{"issue":"12","key":"2303_CR21","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys, M.B., and G.M. Hirschfield. 2003. C-reactive protein: A critical update. The Journal of Clinical Investigation 111 (12): 1805\u20131812.","journal-title":"The Journal of Clinical Investigation"},{"issue":"8","key":"2303_CR22","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1111\/j.1572-0241.2006.00724.x","volume":"101","author":"R Anty","year":"2006","unstructured":"Anty, R., S. Bekri, N. Luciani, M.C. Saint-Paul, M. Dahman, A. Iannelli, et al. 2006. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. American Journal of Gastroenterology 101 (8): 1824\u20131833.","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"2303_CR23","doi-asserted-by":"publisher","first-page":"E105","DOI":"10.1152\/ajpendo.00070.2021","volume":"321","author":"HE Kunz","year":"2021","unstructured":"Kunz, H.E., C.R. Hart, K.J. Gries, M. Parvizi, M. Laurenti, C. Dalla Man, et al. 2021. Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity. American Journal Of Physiology Endocrinology And Metabolism 321 (1): E105\u2013E121.","journal-title":"American Journal Of Physiology Endocrinology And Metabolism"},{"issue":"23","key":"2303_CR24","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.3390\/ijms20236008","volume":"20","author":"S Kany","year":"2019","unstructured":"Kany, S., J.T. Vollrath, and B. Relja. 2019. Cytokines in inflammatory disease. International Journal Of Molecular Sciences 20 (23): 6008.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"6","key":"2303_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0161-5890(03)00148-2","volume":"40","author":"A Agrawal","year":"2003","unstructured":"Agrawal, A., D. Samols, and I. Kushner. 2003. Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C\/EBPbeta to the promoter. Molecular Immunology 40 (6): 373\u2013380.","journal-title":"Molecular Immunology"},{"issue":"8","key":"2303_CR26","doi-asserted-by":"publisher","first-page":"102160","DOI":"10.1016\/j.jbc.2022.102160","volume":"298","author":"MY Wang","year":"2022","unstructured":"Wang, M.Y., C.M. Zhang, H.H. Zhou, Z.B. Ge, C.C. Su, Z.H. Lou, et al. 2022. Identification of a distal enhancer that determines the expression pattern of acute phase marker C-reactive protein. Journal of Biological Chemistry 298 (8): 102160.","journal-title":"Journal of Biological Chemistry"},{"key":"2303_CR27","doi-asserted-by":"publisher","first-page":"e51317","DOI":"10.7554\/eLife.51317","volume":"9","author":"SC Zhang","year":"2020","unstructured":"Zhang, S.C., M.Y. Wang, J.R. Feng, Y. Chang, S.R. Ji, and Y. Wu. 2020. Reversible promoter methylation determines fluctuating expression of acute phase proteins. Elife 9: e51317.","journal-title":"Elife"},{"key":"2303_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston, N.R., and J.J. Ashworth. 2018. Role of C-reactive protein at sites of inflammation and infection. Frontiers in Immunology 9: 754.","journal-title":"Frontiers in Immunology"},{"key":"2303_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-3-030-41769-7_20","volume":"94","author":"JD McFadyen","year":"2020","unstructured":"McFadyen, J.D., J. Zeller, L.A. Potempa, G.A. Pietersz, S.U. Eisenhardt, and K. Peter. 2020. C-Reactive protein and its structural isoforms: An evolutionary conserved marker and central player in inflammatory diseases and beyond. SubCellular Biochemistry 94: 499\u2013520.","journal-title":"SubCellular Biochemistry"},{"issue":"4","key":"2303_CR30","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1172\/JCI116336","volume":"91","author":"DM Vigushin","year":"1993","unstructured":"Vigushin, D.M., M.B. Pepys, and P.N. Hawkins. 1993. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. The Journal of Clinical Investigation 91 (4): 1351\u20131357.","journal-title":"The Journal of Clinical Investigation"},{"issue":"11","key":"2303_CR31","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1515\/hsz-2015-0149","volume":"396","author":"Y Wu","year":"2015","unstructured":"Wu, Y., L.A. Potempa, D. El Kebir, and J.G. Filep. 2015. C-reactive protein and inflammation: Conformational changes affect function. Biological Chemistry 396 (11): 1181\u20131197.","journal-title":"Biological Chemistry"},{"key":"2303_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molimm.2023.03.025","volume":"157","author":"L Zhou","year":"2023","unstructured":"Zhou, L., S.J. Chen, Y. Chang, S.H. Liu, Y.F. Zhou, X.P. Huang, et al. 2023. Monomeric C-reactive protein evokes TCR Signaling-dependent bystander activation of CD4+ T cells. Molecular Immunology 157: 158\u2013166.","journal-title":"Molecular Immunology"},{"key":"2303_CR33","doi-asserted-by":"publisher","first-page":"653045","DOI":"10.1155\/2014\/653045","volume":"2014","author":"J Salazar","year":"2014","unstructured":"Salazar, J., M.S. Martinez, M. Chavez-Castillo, V. Nunez, R. Anez, Y. Torres, et al. 2014. C-reactive protein: An in-depth look into structure, function, and regulation. International scholarly research notices 2014: 653045.","journal-title":"International scholarly research notices"},{"issue":"1","key":"2303_CR34","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41598-018-20014-y","volume":"8","author":"JM Lv","year":"2018","unstructured":"Lv, J.M., S.Q. Lu, Z.P. Liu, J. Zhang, B.X. Gao, Z.Y. Yao, et al. 2018. Conformational folding and disulfide bonding drive distinct stages of protein structure formation. Science and Reports 8 (1): 1494.","journal-title":"Science and Reports"},{"key":"2303_CR35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3389\/fimmu.2018.01089","volume":"9","author":"V Caprio","year":"2018","unstructured":"Caprio, V., L. Badimon, M. Di Napoli, W.H. Fang, G.R. Ferris, B. Guo, et al. 2018. pCRP-mCRP dissociation mechanisms as potential targets for the development of small-molecule anti-inflammatory chemotherapeutics. Frontiers in Immunology 9: 1089.","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"2303_CR36","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1096\/fj.11-186460","volume":"25","author":"M Mihlan","year":"2011","unstructured":"Mihlan, M., A.M. Blom, K. Kupreishvili, N. Lauer, K. Stelzner, F. Bergstrom, et al. 2011. Monomeric C-reactive protein modulates classic complement activation on necrotic cells. The FASEB Journal 25 (12): 4198\u20134210.","journal-title":"The FASEB Journal"},{"issue":"2","key":"2303_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/cvr\/cvr226","volume":"92","author":"B Molins","year":"2011","unstructured":"Molins, B., E. Pena, R. de la Torre, and L. Badimon. 2011. Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow. Cardiovascular Research 92 (2): 328\u2013337.","journal-title":"Cardiovascular Research"},{"issue":"16","key":"2303_CR38","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns, P., B. Iannascoli, P. England, D.A. Mancardi, N. Fernandez, S. Jorieux, et al. 2009. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113 (16): 3716\u20133725.","journal-title":"Blood"},{"issue":"4","key":"2303_CR39","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/01.ATV.0000206211.21895.73","volume":"26","author":"SR Ji","year":"2006","unstructured":"Ji, S.R., Y. Wu, L.A. Potempa, Y.H. Liang, and J. Zhao. 2006. Effect of modified C-reactive protein on complement activation: A possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology 26 (4): 935\u2013941.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"12","key":"2303_CR40","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41374-021-00584-8","volume":"101","author":"C Ruiz-Fernandez","year":"2021","unstructured":"Ruiz-Fernandez, C., M. Gonzalez-Rodriguez, V. Francisco, I.M. Rajab, R. Gomez, J. Conde, et al. 2021. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes. Laboratory Investigation 101 (12): 1550\u20131560.","journal-title":"Laboratory Investigation"},{"issue":"16","key":"2303_CR41","doi-asserted-by":"publisher","first-page":"8795","DOI":"10.1074\/jbc.M115.695023","volume":"291","author":"HY Li","year":"2016","unstructured":"Li, H.Y., J. Wang, F. Meng, Z.K. Jia, Y. Su, Q.F. Bai, et al. 2016. An intrinsically disordered motif mediates diverse actions of monomeric C-reactive protein. Journal of Biological Chemistry 291 (16): 8795\u20138804.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"2303_CR42","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.1038\/ncomms14188","volume":"8","author":"D Braig","year":"2017","unstructured":"Braig, D., T.L. Nero, H.G. Koch, B. Kaiser, X. Wang, J.R. Thiele, et al. 2017. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nature Communications 8 (1): 14188.","journal-title":"Nature Communications"},{"key":"2303_CR43","doi-asserted-by":"publisher","first-page":"979461","DOI":"10.3389\/fcvm.2022.979461","volume":"9","author":"LA Potempa","year":"2022","unstructured":"Potempa, L.A., W.Q. Qiu, A. Stefanski, and I.M. Rajab. 2022. Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities. Frontiers in Cardiovascular Medicine 9: 979461.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"2303_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s41048-015-0003-2","volume":"1","author":"LA Potempa","year":"2015","unstructured":"Potempa, L.A., Z.Y. Yao, S.R. Ji, J.G. Filep, and Y. Wu. 2015. Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification. Biophysics Reports 1 (1): 18\u201333.","journal-title":"Biophysics Reports"},{"issue":"2","key":"2303_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/CIRCRESAHA.108.190611","volume":"105","author":"SU Eisenhardt","year":"2009","unstructured":"Eisenhardt, S.U., J. Habersberger, A. Murphy, Y.C. Chen, K.J. Woollard, N. Bassler, et al. 2009. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circulation Research 105 (2): 128\u2013137.","journal-title":"Circulation Research"},{"issue":"1","key":"2303_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1096\/fj.06-6722com","volume":"21","author":"SR Ji","year":"2007","unstructured":"Ji, S.R., Y. Wu, L. Zhu, L.A. Potempa, F.L. Sheng, W. Lu, et al. 2007. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: MCRP(m). The FASEB Journal 21 (1): 284\u2013294.","journal-title":"The FASEB Journal"},{"issue":"1","key":"2303_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcmgh.2021.09.003","volume":"13","author":"HY Li","year":"2022","unstructured":"Li, H.Y., Z.M. Tang, Z. Wang, J.M. Lv, X.L. Liu, Y.L. Liang, et al. 2022. C-reactive protein protects against acetaminophen-induced liver injury by preventing complement overactivation. Cellular and Molecular Gastroenterology and Hepatology 13 (1): 289\u2013307.","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"2303_CR48","doi-asserted-by":"publisher","first-page":"918731","DOI":"10.3389\/fimmu.2022.918731","volume":"13","author":"HY Li","year":"2022","unstructured":"Li, H.Y., N. Gao, C.Y. Liu, X.L. Liu, F. Wu, N. Dai, et al. 2022. The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with angiotensin-converting enzyme 2. Frontiers in Immunology 13: 918731.","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"2303_CR49","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1096\/fj.11-182741","volume":"25","author":"MY Wang","year":"2011","unstructured":"Wang, M.Y., S.R. Ji, C.J. Bai, D. El Kebir, H.Y. Li, J.M. Shi, et al. 2011. A redox switch in C-reactive protein modulates activation of endothelial cells. The FASEB Journal 25 (9): 3186\u20133196.","journal-title":"The FASEB Journal"},{"issue":"3","key":"2303_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1302\/2046-3758.123.BJR-2022-0223.R1","volume":"12","author":"C Ruiz-Fern\u00e1ndez","year":"2023","unstructured":"Ruiz-Fern\u00e1ndez, C., D. Ait Eldjoudi, M. Gonz\u00e1lez-Rodr\u00edguez, A. Cordero Barreal, Y. Farrag, L. Garc\u00eda-Caballero, et al. 2023. Monomeric CRP regulates inflammatory responses in human intervertebral disc cells. Bone Joint Res. 12 (3): 189\u2013198.","journal-title":"Bone Joint Res."},{"issue":"1","key":"2303_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","volume":"9","author":"Y Song","year":"2024","unstructured":"Song, Y., J. Li, and Y. Wu. 2024. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduction and Targeted Therapy 9 (1): 263.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2303_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-720-4_1","volume":"900","author":"A Perl","year":"2012","unstructured":"Perl, A. 2012. Pathogenesis and spectrum of autoimmunity. Methods in Molecular Biology 900: 1\u20139.","journal-title":"Methods in Molecular Biology"},{"key":"2303_CR53","doi-asserted-by":"publisher","first-page":"3706508","DOI":"10.1155\/2022\/3706508","volume":"2022","author":"J Stanimirovic","year":"2022","unstructured":"Stanimirovic, J., J. Radovanovic, K. Banjac, M. Obradovic, M. Essack, S. Zafirovic, et al. 2022. Role of C-reactive protein in diabetic inflammation. Mediators of Inflammation 2022: 3706508.","journal-title":"Mediators of Inflammation"},{"issue":"11","key":"2303_CR54","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/molecules24112062","volume":"24","author":"M Boncler","year":"2019","unstructured":"Boncler, M., Y. Wu, and C. Watala. 2019. The Multiple Faces of C-Reactive Protein-Physiological and Pathophysiological Implications in Cardiovascular Disease. Molecules 24 (11): 2062.","journal-title":"Molecules"},{"issue":"11","key":"2303_CR55","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.4049\/jimmunol.1402909","volume":"194","author":"L Zhang","year":"2015","unstructured":"Zhang, L., S.H. Liu, T.T. Wright, Z.Y. Shen, H.Y. Li, W. Zhu, et al. 2015. C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis. The Journal of Immunology 194 (11): 5243\u20135252.","journal-title":"The Journal of Immunology"},{"issue":"13\u201314","key":"2303_CR56","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.clinbiochem.2017.03.010","volume":"50","author":"K Jakuszko","year":"2017","unstructured":"Jakuszko, K., M. Krajewska, K. Koscielska-Kasprzak, M. Myszka, A. Sebastian, K. Gniewek, et al. 2017. Antibodies against monomeric C-reactive protein - a promising biomarker of lupus nephritis? Clinical Biochemistry 50 (13\u201314): 756\u2013762.","journal-title":"Clinical Biochemistry"},{"key":"2303_CR57","doi-asserted-by":"publisher","first-page":"938173","DOI":"10.3389\/fimmu.2022.938173","volume":"13","author":"C Fujita","year":"2022","unstructured":"Fujita, C., Y. Sakurai, Y. Yasuda, R. Homma, C.L. Huang, and M. Fujita. 2022. mCRP as a biomarker of adult-onset still\u2019s disease: Quantification of mCRP by ELISA. Frontiers in Immunology 13: 938173.","journal-title":"Frontiers in Immunology"},{"issue":"20","key":"2303_CR58","doi-asserted-by":"publisher","first-page":"14283","DOI":"10.1074\/jbc.M114.555318","volume":"289","author":"HY Li","year":"2014","unstructured":"Li, H.Y., J. Wang, Y.X. Wu, L. Zhang, Z.P. Liu, J.G. Filep, et al. 2014. Topological localization of monomeric C-reactive protein determines proinflammatory endothelial cell responses. Journal of Biological Chemistry 289 (20): 14283\u201314290.","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"2303_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000530928","volume":"9","author":"M Yuan","year":"2023","unstructured":"Yuan, M., Y. Tan, and M.H. Zhao. 2023. The role of anti-mCRP autoantibodies in Lupus Nephritis. Kidney Dis (Basel). 9 (5): 317\u2013325.","journal-title":"Kidney Dis (Basel)."},{"issue":"10","key":"2303_CR60","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1681\/ASN.2016070735","volume":"28","author":"QY Li","year":"2017","unstructured":"Li, Q.Y., H.Y. Li, G. Fu, F. Yu, Y. Wu, and M.H. Zhao. 2017. Autoantibodies against C-reactive protein influence complement activation and clinical course in lupus nephritis. Journal of the American Society of Nephrology 28 (10): 3044\u20133054.","journal-title":"Journal of the American Society of Nephrology"},{"key":"2303_CR61","doi-asserted-by":"crossref","unstructured":"Jiang S, D.X, and Samols D. 2006. Expression of rabbit C\u2010reactive protein in transgenic mice inhibits development of antigen\u2010induced arthritis. Scandinavian Journal of Rheumatology 35(5):351-5","DOI":"10.1080\/03009740600757963"},{"issue":"9","key":"2303_CR62","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/art.30444","volume":"63","author":"NR Jones","year":"2011","unstructured":"Jones, N.R., M.A. Pegues, M.A. McCrory, S.W. Kerr, H. Jiang, R. Sellati, et al. 2011. Collagen-induced arthritis is exacerbated in C-reactive protein\u2013deficient mice. Arthritis & Rheumatism 63 (9): 2641\u20132650.","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"2303_CR63","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4049\/jimmunol.178.1.530","volume":"178","author":"W Rodriguez","year":"2007","unstructured":"Rodriguez, W., C. Mold, M. Kataranovski, J.A. Hutt, L.L. Marnell, J.S. Verbeek, et al. 2007. C-Reactive protein-mediated suppression of nephrotoxic nephritis: Role of macrophages, complement, and fc\u03b3 receptors1. The Journal of Immunology. 178 (1): 530\u2013538.","journal-title":"The Journal of Immunology."},{"key":"2303_CR64","first-page":"640171","volume":"2015","author":"TT Wright","year":"2015","unstructured":"Wright, T.T., R.V. Jimenez, T.E. Morgan, N. Bali, X. Hou, M.A. McCrory, et al. 2015. Hepatic but Not CNS-expressed human c-reactive protein inhibits experimental autoimmune encephalomyelitis in transgenic mice. Autoimmune Dis. 2015: 640171.","journal-title":"Autoimmune Dis."},{"key":"2303_CR65","doi-asserted-by":"publisher","unstructured":"Singh, S.K., A. Prislovsky, D.N. Ngwa, U. Munkhsaikhan, A.H. Abidi, D.D. Brand, and A. Agrawal. 2024. C-reactive protein lowers the serum level of IL-17, but not TNF-\u03b1, and decreases the incidence of collagen-induced arthritis in mice. Frontiers in immunology 15:\u00a01385085. https:\/\/doi.org\/10.3389\/fimmu.2024.1385085.","DOI":"10.3389\/fimmu.2024.1385085"},{"key":"2303_CR66","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fimmu.2019.00943","volume":"10","author":"A Pathak","year":"2019","unstructured":"Pathak, A., and A. Agrawal. 2019. Evolution of C-reactive protein. Frontiers in Immunology 10: 943.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"2303_CR67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s100380050022","volume":"45","author":"H Cao","year":"2000","unstructured":"Cao, H., and R.A. Hegele. 2000. Human C-reactive protein (CRP) 1059G\/C polymorphism. Journal of Human Genetics 45 (2): 100\u2013101.","journal-title":"Journal of Human Genetics"},{"issue":"1","key":"2303_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.gene.6363820","volume":"3","author":"AJ Szalai","year":"2002","unstructured":"Szalai, A.J., M. McCrory, G. Cooper, J. Wu, and R. Kimberly. 2002. Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes & Immunity. 3 (1): 14\u201319.","journal-title":"Genes & Immunity."},{"issue":"1","key":"2303_CR69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/ddh021","volume":"13","author":"AI Russell","year":"2004","unstructured":"Russell, A.I., D.S. Cunninghame Graham, C. Shepherd, C.A. Roberton, J. Whittaker, J. Meeks, et al. 2004. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Human Molecular Genetics 13 (1): 137\u2013147.","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"2303_CR70","first-page":"e16859","volume":"13","author":"OE Okobi","year":"2021","unstructured":"Okobi, O.E., I.O. Udoete, O.O. Fasehun, T. Okobi, E.O. Evbayekha, J.J. Ekabua, et al. 2021. A review of four practice guidelines of inflammatory bowel disease. Cureus. 13 (8): e16859.","journal-title":"Cureus."},{"issue":"1","key":"2303_CR71","first-page":"33","volume":"9","author":"Y Haonan","year":"2023","unstructured":"Haonan, Y., and L. Zhihua. 2023. GNA12 regulates C5a-induced migration by downregulating C5aR1-PLC\u03b22-PI3K-AKT-ERK1\/2 signaling. Biophysics Reports. 9 (1): 33\u201344.","journal-title":"Biophysics Reports."},{"key":"2303_CR72","unstructured":"Walfish, A. E., and Ching Companioni, R. A. 2023. Overview of inflammatory bowel disease. MSD Manual Professional Version. Retrieved June 25, 2024, from https:\/\/www.msdmanuals.com\/professional\/gastrointestinal-disorders\/inflammatory-bowel-disease-ibd\/overview-of-inflammatory-bowel-disease."},{"issue":"10114","key":"2303_CR73","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng, S.C., H.Y. Shi, N. Hamidi, F.E. Underwood, W. Tang, E.I. Benchimol, et al. 2017. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 390 (10114): 2769\u20132778.","journal-title":"Lancet"},{"key":"2303_CR74","doi-asserted-by":"publisher","first-page":"1032679","DOI":"10.3389\/fpubh.2022.1032679","volume":"10","author":"B Shao","year":"2022","unstructured":"Shao, B., W. Yang, and Q. Cao. 2022. Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030. Frontiers in Public Health 10: 1032679.","journal-title":"Frontiers in Public Health"},{"issue":"5","key":"2303_CR75","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/00054725-200409000-00026","volume":"10","author":"S Vermeire","year":"2004","unstructured":"Vermeire, S., G. Van Assche, and P. Rutgeerts. 2004. C-reactive protein as a marker for inflammatory bowel disease. Inflammatory Bowel Diseases 10 (5): 661\u2013665.","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"2303_CR76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000527846","volume":"104","author":"T Sakurai","year":"2023","unstructured":"Sakurai, T., and M. Saruta. 2023. Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease. Digestion 104 (1): 30\u201341.","journal-title":"Digestion"},{"issue":"5","key":"2303_CR77","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-2036.2011.04987.x","volume":"35","author":"W Reinisch","year":"2012","unstructured":"Reinisch, W., Y. Wang, B.J. Oddens, and R. Link. 2012. C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn\u2019s disease: A post-hoc analysis from ACCENT I. Alimentary Pharmacology & Therapeutics 35 (5): 568\u2013576.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"10","key":"2303_CR78","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/gut.2007.134817","volume":"57","author":"A Bitton","year":"2008","unstructured":"Bitton, A., P.L. Dobkin, M.D. Edwardes, M.J. Sewitch, J.B. Meddings, S. Rawal, et al. 2008. Predicting relapse in Crohn\u2019s disease: A biopsychosocial model. Gut 57 (10): 1386\u20131392.","journal-title":"Gut"},{"issue":"8","key":"2303_CR79","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1365-2036.2011.04827.x","volume":"34","author":"LS Kiss","year":"2011","unstructured":"Kiss, L.S., T. Szamosi, T. Molnar, P. Miheller, L. Lakatos, A. Vincze, et al. 2011. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn\u2019s disease. Alimentary Pharmacology & Therapeutics 34 (8): 911\u2013922.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"2303_CR80","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","volume":"96","author":"SB Hanauer","year":"2001","unstructured":"Hanauer, S.B., and W. Sandborn. 2001. Practice parameters committee of the american college of G. Management of Crohn\u2019s disease in adults. Am J Gastroenterol 96 (3): 635\u201343.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2303_CR81","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.ibd.0000225334.60990.5b","volume":"12","author":"Y Consigny","year":"2006","unstructured":"Consigny, Y., R. Modigliani, J.F. Colombel, J.L. Dupas, M. Lemann, J.Y. Mary, et al. 2006. A simple biological score for predicting low risk of short-term relapse in Crohn\u2019s disease. Inflammatory Bowel Diseases 12 (7): 551\u2013557.","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"2303_CR82","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00042737-200204000-00013","volume":"14","author":"AP Poullis","year":"2002","unstructured":"Poullis, A.P., S. Zar, K.K. Sundaram, S.J. Moodie, P. Risley, A. Theodossi, et al. 2002. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. European Journal of Gastroenterology and Hepatology 14 (4): 409\u2013412.","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"40","key":"2303_CR83","doi-asserted-by":"publisher","first-page":"11246","DOI":"10.3748\/wjg.v21.i40.11246","volume":"21","author":"S Chang","year":"2015","unstructured":"Chang, S., L. Malter, and D. Hudesman. 2015. Disease monitoring in inflammatory bowel disease. World Journal of Gastroenterology 21 (40): 11246\u201311259.","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"2303_CR84","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2362.1982.tb02244.x","volume":"12","author":"EA Fagan","year":"1982","unstructured":"Fagan, E.A., R.F. Dyck, P.N. Maton, H.J. Hodgson, V.S. Chadwick, A. Petrie, et al. 1982. Serum levels of C-reactive protein in Crohn\u2019s disease and ulcerative colitis. European Journal of Clinical Investigation 12 (4): 351\u2013359.","journal-title":"European Journal of Clinical Investigation"},{"issue":"1","key":"2303_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ecco-jcc\/jjx101","volume":"12","author":"G Doherty","year":"2018","unstructured":"Doherty, G., K.H. Katsanos, J. Burisch, M. Allez, K. Papamichael, A. Stallmach, et al. 2018. European Crohn\u2019s and colitis organisation topical review on treatment withdrawal [\u2019Exit Strategies\u2019] in inflammatory bowel disease. Journal of Crohn\u2019s & Colitis 12 (1): 17\u201331.","journal-title":"Journal of Crohn's & Colitis"},{"issue":"9","key":"2303_CR86","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/ibd.21933","volume":"18","author":"LS Kiss","year":"2012","unstructured":"Kiss, L.S., M. Papp, B.D. Lovasz, Z. Vegh, P.A. Golovics, E. Janka, et al. 2012. High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn\u2019s disease: A marker for patient classification? Inflammatory Bowel Diseases 18 (9): 1647\u20131654.","journal-title":"Inflammatory Bowel Diseases"},{"issue":"3","key":"2303_CR87","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1172\/JCI119561","volume":"100","author":"C Zouki","year":"1997","unstructured":"Zouki, C., M. Beauchamp, C. Baron, and J.G. Filep. 1997. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. The Journal of Clinical Investigation 100 (3): 522\u2013529.","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"2303_CR88","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ncpgasthep0359","volume":"2","author":"S Vermeire","year":"2005","unstructured":"Vermeire, S., G. Van Assche, and P. Rutgeerts. 2005. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nature Clinical Practice. Gastroenterology & Hepatology 2 (12): 580\u2013586.","journal-title":"Nature Clinical Practice. Gastroenterology & Hepatology"},{"issue":"2","key":"2303_CR89","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.biocel.2004.07.002","volume":"37","author":"RM Heuertz","year":"2005","unstructured":"Heuertz, R.M., G.P. Schneider, L.A. Potempa, and R.O. Webster. 2005. Native and modified C-reactive protein bind different receptors on human neutrophils. The International Journal of Biochemistry & Cell Biology. 37 (2): 320\u2013335.","journal-title":"The International Journal of Biochemistry & Cell Biology."},{"issue":"13","key":"2303_CR90","doi-asserted-by":"publisher","first-page":"10899","DOI":"10.3390\/ijms241310899","volume":"24","author":"J Xu","year":"2023","unstructured":"Xu, J., G. Molin, S. Davidson, B. Roth, K. Sj\u00f6berg, and \u00c5. H\u00e5kansson. 2023. CRP in Outpatients with Inflammatory Bowel Disease Is Linked to the Blood Microbiota. International journal of molecular sciences 24 (13): 10899. https:\/\/doi.org\/10.3390\/ijms241310899.","journal-title":"International journal of molecular sciences"},{"issue":"3","key":"2303_CR91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/jaut.2002.0608","volume":"19","author":"C Sjowall","year":"2002","unstructured":"Sjowall, C., P. Eriksson, S. Almer, and T. Skogh. 2002. Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren\u2019s syndrome, rheumatoid arthritis or inflammatory bowel disease. Journal of Autoimmunity 19 (3): 155\u2013160.","journal-title":"Journal of Autoimmunity"},{"issue":"5","key":"2303_CR92","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/joim.13058","volume":"287","author":"L Klareskog","year":"2020","unstructured":"Klareskog, L., J. Ronnelid, S. Saevarsdottir, L. Padyukov, and L. Alfredsson. 2020. The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis. Journal of Internal Medicine 287 (5): 514\u2013533.","journal-title":"Journal of Internal Medicine"},{"key":"2303_CR93","doi-asserted-by":"publisher","first-page":"3830212","DOI":"10.1155\/2020\/3830212","volume":"2020","author":"Q Fang","year":"2020","unstructured":"Fang, Q., C. Zhou, and K.S. Nandakumar. 2020. Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators of Inflammation 2020: 3830212.","journal-title":"Mediators of Inflammation"},{"issue":"6","key":"2303_CR94","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.27425","volume":"62","author":"E Myasoedova","year":"2010","unstructured":"Myasoedova, E., C.S. Crowson, H.M. Kremers, T.M. Therneau, and S.E. Gabriel. 2010. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955\u20132007. Arthritis and Rheumatism 62 (6): 1576\u20131582.","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"2303_CR95","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.30155","volume":"63","author":"CS Crowson","year":"2011","unstructured":"Crowson, C.S., E.L. Matteson, E. Myasoedova, C.J. Michet, F.C. Ernste, K.J. Warrington, et al. 2011. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis and Rheumatism 63 (3): 633\u2013639.","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"2303_CR96","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3899\/jrheum.200367","volume":"48","author":"KB Almutairi","year":"2021","unstructured":"Almutairi, K.B., J.C. Nossent, D.B. Preen, H.I. Keen, and C.A. Inderjeeth. 2021. The prevalence of rheumatoid arthritis: a systematic review of population-based studies. Journal of Rheumatology 48 (5): 669\u2013676.","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"2303_CR97","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados, M., M. Soubrier, A. Antunez, P. Balint, A. Balsa, M.H. Buch, et al. 2014. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: Results of an international, cross-sectional study (COMORA). Annals of the rheumatic diseases. 73 (1): 62\u201368.","journal-title":"Annals of the rheumatic diseases."},{"issue":"4","key":"2303_CR98","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/art.24385","volume":"60","author":"D van der Woude","year":"2009","unstructured":"van der Woude, D., J.J. Houwing-Duistermaat, R.E. Toes, T.W. Huizinga, W. Thomson, J. Worthington, et al. 2009. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis and Rheumatism 60 (4): 916\u2013923.","journal-title":"Arthritis and Rheumatism"},{"key":"2303_CR99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2015.07.007","volume":"64","author":"TC Messemaker","year":"2015","unstructured":"Messemaker, T.C., T.W. Huizinga, and F. Kurreeman. 2015. Immunogenetics of rheumatoid arthritis: Understanding functional implications. Journal of Autoimmunity 64: 74\u201381.","journal-title":"Journal of Autoimmunity"},{"issue":"11","key":"2303_CR100","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1007\/s10067-022-06306-9","volume":"41","author":"S Liu","year":"2022","unstructured":"Liu, S., J. Li, Y. Li, Y. Liu, K. Wang, and W. Pan. 2022. Correlation of CRP genotypes with serum CRP levels and the risk of rheumatoid arthritis in Chinese Han population. Clinical Rheumatology 41 (11): 3325\u20133330.","journal-title":"Clinical Rheumatology"},{"issue":"10","key":"2303_CR101","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.biopha.2006.09.003","volume":"60","author":"G Orozco","year":"2006","unstructured":"Orozco, G., B. Rueda, and J. Martin. 2006. Genetic basis of rheumatoid arthritis. Biomedicine & Pharmacotherapy 60 (10): 656\u2013662.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"8","key":"2303_CR102","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/annrheumdis-2013-204796","volume":"74","author":"R Bayley","year":"2015","unstructured":"Bayley, R., K.A. Kite, H.M. McGettrick, J.P. Smith, G.D. Kitas, C.D. Buckley, et al. 2015. The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals. Annals of the Rheumatic Diseases 74 (8): 1588\u20131595.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1\u20132","key":"2303_CR103","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11010-011-1109-6","volume":"361","author":"C Rong","year":"2012","unstructured":"Rong, C., W. Hu, F.R. Wu, X.J. Cao, and F.H. Chen. 2012. Interleukin-23 as a potential therapeutic target for rheumatoid arthritis. Molecular and Cellular Biochemistry 361 (1\u20132): 243\u2013248.","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"2303_CR104","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ni.3618","volume":"18","author":"AA Abdul-Sater","year":"2017","unstructured":"Abdul-Sater, A.A., M.I. Edilova, D.L. Clouthier, A. Mbanwi, E. Kremmer, and T.H. Watts. 2017. The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease. Nature Immunology 18 (1): 26\u201335.","journal-title":"Nature Immunology"},{"issue":"2","key":"2303_CR105","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","volume":"45","author":"J Kurko","year":"2013","unstructured":"Kurko, J., T. Besenyei, J. Laki, T.T. Glant, K. Mikecz, and Z. Szekanecz. 2013. Genetics of rheumatoid arthritis - a comprehensive review. Clinical Reviews in Allergy and Immunology 45 (2): 170\u2013179.","journal-title":"Clinical Reviews in Allergy and Immunology"},{"issue":"12","key":"2303_CR106","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1002\/art.39321","volume":"67","author":"P Duffau","year":"2015","unstructured":"Duffau, P., H. Menn-Josephy, C.M. Cuda, S. Dominguez, T.R. Aprahamian, A.A. Watkins, et al. 2015. Promotion of inflammatory arthritis by interferon regulatory factor 5 in a mouse model. Arthritis & Rhematology 67 (12): 3146\u20133157.","journal-title":"Arthritis & Rhematology"},{"issue":"4","key":"2303_CR107","doi-asserted-by":"publisher","first-page":"709","DOI":"10.17219\/acem\/61034","volume":"25","author":"J Swierkot","year":"2016","unstructured":"Swierkot, J., B. Nowak, A. Czarny, E. Zaczynska, R. Sokolik, M. Madej, et al. 2016. The Activity of JAK\/STAT and NF-kappaB in patients with rheumatoid arthritis. Adv Clin Exp Med. 25 (4): 709\u2013717.","journal-title":"Adv Clin Exp Med."},{"issue":"1","key":"2303_CR108","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1124\/jpet.116.237669","volume":"360","author":"B Julian","year":"2017","unstructured":"Julian, B., K. Gao, B.N. Harwood, M. Beinborn, and A.S. Kopin. 2017. Mutation-induced functional alterations of CCR6. Journal of Pharmacology and Experimental Therapeutics 360 (1): 106\u2013116.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"2303_CR109","doi-asserted-by":"publisher","first-page":"358","DOI":"10.7150\/ijbs.16879","volume":"13","author":"L Fan","year":"2017","unstructured":"Fan, L., M. Zong, R. Gong, D. He, N. Li, L.S. Sun, et al. 2017. PADI4 Epigenetically suppresses p21 Transcription and inhibits cell apoptosis in fibroblast-like synoviocytes from rheumatoid arthritis patients. International Journal of Biological Sciences 13 (3): 358\u2013366.","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"2303_CR110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12026-013-8384-0","volume":"56","author":"W Ansar","year":"2013","unstructured":"Ansar, W., and S. Ghosh. 2013. C-reactive protein and the biology of disease. Immunologic Research 56 (1): 131\u2013142.","journal-title":"Immunologic Research"},{"key":"2303_CR111","doi-asserted-by":"publisher","first-page":"372432","DOI":"10.1155\/2015\/372432","volume":"2015","author":"JR Thiele","year":"2015","unstructured":"Thiele, J.R., J. Zeller, H. Bannasch, G.B. Stark, K. Peter, and S.U. Eisenhardt. 2015. Targeting C-reactive protein in inflammatory disease by preventing conformational changes. Mediators of Inflammation 2015: 372432.","journal-title":"Mediators of Inflammation"},{"issue":"1","key":"2303_CR112","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","volume":"51","author":"JE Pope","year":"2021","unstructured":"Pope, J.E., and E.H. Choy. 2021. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Seminars in Arthritis and Rheumatism 51 (1): 219\u2013229.","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"2303_CR113","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fmed.2018.00185","volume":"5","author":"CK Orr","year":"2018","unstructured":"Orr, C.K., A. Najm, F. Young, T. McGarry, M. Biniecka, U. Fearon, et al. 2018. The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Front Med (Lausanne). 5: 185.","journal-title":"Front Med (Lausanne)."},{"issue":"1","key":"2303_CR114","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13075-015-0563-z","volume":"17","author":"KW Kim","year":"2015","unstructured":"Kim, K.W., B.M. Kim, H.W. Moon, S.H. Lee, and H.R. Kim. 2015. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis. Arthritis Research & Therapy 17 (1): 41.","journal-title":"Arthritis Research & Therapy"},{"key":"2303_CR115","doi-asserted-by":"publisher","unstructured":"Meyer, P.W., B. Hodkinson, M. Ally, E. Musenge, A.A. Wadee, H. Fickl, M. Tikly, and R. Anderson. 2010. Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators of Inflammation 2010: 158514. https:\/\/doi.org\/10.1155\/2010\/158514.","DOI":"10.1155\/2010\/158514"},{"issue":"1","key":"2303_CR116","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2478\/v10039-010-0006-7","volume":"55","author":"B Cylwik","year":"2010","unstructured":"Cylwik, B., L. Chrostek, E. Gindzienska-Sieskiewicz, S. Sierakowski, and M. Szmitkowski. 2010. Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis. Advances in medical sciences. 55 (1): 80\u201385.","journal-title":"Advances in medical sciences."},{"issue":"4","key":"2303_CR117","first-page":"423","volume":"34","author":"K Yildirim","year":"2004","unstructured":"Yildirim, K., S. Karatay, M.A. Melikoglu, G. Gureser, M. Ugur, and K. Senel. 2004. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Annals of clinical & laboratory science. 34 (4): 423\u2013426.","journal-title":"Annals of clinical & laboratory science."},{"issue":"10","key":"2303_CR118","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/ard.60.10.924","volume":"60","author":"LM Jansen","year":"2001","unstructured":"Jansen, L.M., I.E. van der Horst-Bruinsma, D. van Schaardenburg, P.D. Bezemer, and B.A. Dijkmans. 2001. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases 60 (10): 924\u2013927.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"2303_CR119","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41927-019-0052-0","volume":"3","author":"AC Bay-Jensen","year":"2019","unstructured":"Bay-Jensen, A.C., A. Platt, M.A. Jenkins, M.E. Weinblatt, I. Byrjalsen, K. Musa, et al. 2019. Tissue metabolite of type I collagen, C1M, and CRP predicts structural progression of rheumatoid arthritis. BMC Rheumatol. 3 (1): 3.","journal-title":"BMC Rheumatol."},{"issue":"9","key":"2303_CR120","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/03007995.2019.1585064","volume":"35","author":"JR Curtis","year":"2019","unstructured":"Curtis, J.R., C.H. Brahe, M. Ostergaard, M. Lund Hetland, K. Hambardzumyan, S. Saevarsdottir, et al. 2019. Predicting risk for radiographic damage in rheumatoid arthritis: Comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies. Current Medical Research and Opinion 35 (9): 1483\u20131493.","journal-title":"Current Medical Research and Opinion"},{"issue":"7","key":"2303_CR121","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3899\/jrheum.080770","volume":"36","author":"T Sokka","year":"2009","unstructured":"Sokka, T., and T. Pincus. 2009. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%\u201345% of patients with rheumatoid arthritis seen between 1980 and 2004: Analyses from Finland and the United States. The Journal of rheumatology 36 (7): 1387\u20131390.","journal-title":"The Journal of rheumatology"},{"issue":"1","key":"2303_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4469","volume":"16","author":"J Kay","year":"2014","unstructured":"Kay, J., O. Morgacheva, S.P. Messing, J.M. Kremer, J.D. Greenberg, G.W. Reed, et al. 2014. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: Acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis Research & Therapy 16 (1): 1\u201310.","journal-title":"Arthritis Research & Therapy"},{"key":"2303_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1346-5","volume":"19","author":"M Schoels","year":"2017","unstructured":"Schoels, M., F. Alasti, J. Smolen, and D. Aletaha. 2017. Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition. Arthritis Research & Therapy 19: 1\u20136.","journal-title":"Arthritis Research & Therapy"},{"issue":"6","key":"2303_CR124","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/acr.22765","volume":"68","author":"J Wang","year":"2016","unstructured":"Wang, J., J. Devenport, J.M. Low, D. Yu, and E. Hitraya. 2016. Relationship between baseline and early changes in C-reactive protein and interleukin-6 levels and clinical response to tocilizumab in rheumatoid arthritis. Arthritis Care & Research 68 (6): 882\u2013885.","journal-title":"Arthritis Care & Research"},{"key":"2303_CR125","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fimmu.2018.00234","volume":"9","author":"ZK Jia","year":"2018","unstructured":"Jia, Z.K., H.Y. Li, Y.L. Liang, L.A. Potempa, S.R. Ji, and Y. Wu. 2018. Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-kappaB Ligand-Induced Osteoclast Differentiation. Frontiers in Immunology 9: 234.","journal-title":"Frontiers in Immunology"},{"key":"2303_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2015.12.021","volume":"145","author":"IJ Cho","year":"2016","unstructured":"Cho, I.J., K.H. Choi, C.H. Oh, Y.C. Hwang, I.K. Jeong, K.J. Ahn, et al. 2016. Effects of C-reactive protein on bone cells. Life Sciences 145: 1\u20138.","journal-title":"Life Sciences"},{"issue":"8","key":"2303_CR127","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/gene.2011.45","volume":"12","author":"E Karouzakis","year":"2011","unstructured":"Karouzakis, E., Y. Rengel, A. Jungel, C. Kolling, R.E. Gay, B.A. Michel, et al. 2011. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes and Immunity 12 (8): 643\u2013652.","journal-title":"Genes and Immunity"},{"key":"2303_CR128","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/0003-4819-57-2-305","volume":"57","author":"GP Rodnan","year":"1962","unstructured":"Rodnan, G.P., and T.G. Benedek. 1962. An historical account of the study of progressive systemic sclerosis (diffuse scleroderma). Annals of Internal Medicine 57: 305\u2013319.","journal-title":"Annals of Internal Medicine"},{"issue":"10103","key":"2303_CR129","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C.P., and D. Khanna. 2017. Systemic sclerosis. Lancet 390 (10103): 1685\u20131699.","journal-title":"Lancet"},{"issue":"1","key":"2303_CR130","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/self.2.1.14058","volume":"2","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto, T. 2011. Autoimmune mechanisms of scleroderma and a role of oxidative stress. Self Nonself. 2 (1): 4\u201310.","journal-title":"Self Nonself."},{"issue":"5","key":"2303_CR131","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/BOR.0b013e328309a5eb","volume":"20","author":"F Zulian","year":"2008","unstructured":"Zulian, F. 2008. New developments in localized scleroderma. Current Opinion in Rheumatology 20 (5): 601\u2013607.","journal-title":"Current Opinion in Rheumatology"},{"issue":"3","key":"2303_CR132","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mpmed.2013.12.004","volume":"42","author":"EC Derrett-Smith","year":"2014","unstructured":"Derrett-Smith, E.C., and C.P. Denton. 2014. Systemic sclerosis: Clinical features and management. Medicine 42 (3): 167\u2013173.","journal-title":"Medicine"},{"issue":"11","key":"2303_CR133","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai, M., C. Meune, M. Boubaya, J. Avouac, E. Hachulla, A. Balbir-Gurman, et al. 2017. Mapping and predicting mortality from systemic sclerosis. Annals of the Rheumatic Diseases 76 (11): 1897\u20131905.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2303_CR134","doi-asserted-by":"crossref","unstructured":"Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, et al. 1996. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis and Rheumatism 39(8):1362\u201370","DOI":"10.1002\/art.1780390814"},{"issue":"4","key":"2303_CR135","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","volume":"37","author":"H Chifflot","year":"2008","unstructured":"Chifflot, H., B. Fautrel, C. Sordet, E. Chatelus, and J. Sibilia. 2008. Incidence and prevalence of systemic sclerosis: A systematic literature review. Seminars in Arthritis and Rheumatism 37 (4): 223\u2013235.","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"4","key":"2303_CR136","doi-asserted-by":"publisher","first-page":"101981","DOI":"10.1016\/j.berh.2024.101981","volume":"38","author":"A El-Halwagi","year":"2024","unstructured":"El-Halwagi, A., and S.K. Agarwal. 2024. Insights into the genetic landscape of systemic sclerosis. Best Practice & Research Clinical Rheumatology 38 (4): 101981.","journal-title":"Best Practice & Research Clinical Rheumatology"},{"issue":"6","key":"2303_CR137","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","volume":"44","author":"FC Arnett","year":"2001","unstructured":"Arnett, F.C., M. Cho, S. Chatterjee, M.B. Aguilar, J.D. Reveille, and M.D. Mayes. 2001. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis and Rheumatism 44 (6): 1359\u20131362.","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"2303_CR138","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.autrev.2016.01.016","volume":"15","author":"G Murdaca","year":"2016","unstructured":"Murdaca, G., M. Contatore, R. Gulli, P. Mandich, and F. Puppo. 2016. Genetic factors and systemic sclerosis. Autoimmunity Reviews 15 (5): 427\u2013432.","journal-title":"Autoimmunity Reviews"},{"issue":"1","key":"2303_CR139","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/1346-8138.13221","volume":"43","author":"T Makino","year":"2016","unstructured":"Makino, T., and M. Jinnin. 2016. Genetic and epigenetic abnormalities in systemic sclerosis. Journal of Dermatology 43 (1): 10\u201318.","journal-title":"Journal of Dermatology"},{"issue":"2","key":"2303_CR140","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","volume":"38","author":"YS Gu","year":"2008","unstructured":"Gu, Y.S., J. Kong, G.S. Cheema, C.L. Keen, G. Wick, and M.E. Gershwin. 2008. The immunobiology of systemic sclerosis. Seminars in Arthritis and Rheumatism 38 (2): 132\u2013160.","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"2303_CR141","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41232-021-00167-6","volume":"41","author":"Y Ota","year":"2021","unstructured":"Ota, Y., and M. Kuwana. 2021. Updates on genetics in systemic sclerosis. Inflamm Regen. 41 (1): 17.","journal-title":"Inflamm Regen."},{"issue":"5","key":"2303_CR142","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/ard.2009.111906","volume":"69","author":"FC Arnett","year":"2010","unstructured":"Arnett, F.C., P. Gourh, S. Shete, C.W. Ahn, R.E. Honey, S.K. Agarwal, et al. 2010. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: Analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Annals of the Rheumatic Diseases 69 (5): 822\u2013827.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"2303_CR143","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/ard.2010.130138","volume":"70","author":"LM Diaz-Gallo","year":"2011","unstructured":"Diaz-Gallo, L.M., P. Gourh, J. Broen, C. Simeon, V. Fonollosa, N. Ortego-Centeno, et al. 2011. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Annals of the Rheumatic Diseases 70 (3): 454\u2013462.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"2303_CR144","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/ard.2010.131243","volume":"70","author":"P Dieude","year":"2011","unstructured":"Dieude, P., M. Guedj, J. Wipff, B. Ruiz, G. Riemekasten, P. Airo, et al. 2011. NLRP1 influences the systemic sclerosis phenotype: A new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Annals of the Rheumatic Diseases 70 (4): 668\u2013674.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"2303_CR145","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/039463201302600220","volume":"26","author":"L Yi","year":"2013","unstructured":"Yi, L., J.C. Wang, X.J. Guo, Y.H. Gu, W.Z. Tu, G. Guo, et al. 2013. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population. International Journal of Immunopathology and Pharmacology 26 (2): 473\u2013478.","journal-title":"International Journal of Immunopathology and Pharmacology"},{"issue":"6","key":"2303_CR146","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/jmg.2007.055012","volume":"45","author":"G Kristjansdottir","year":"2008","unstructured":"Kristjansdottir, G., J.K. Sandling, A. Bonetti, I.M. Roos, L. Milani, C. Wang, et al. 2008. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. Journal of Medical Genetics 45 (6): 362\u2013369.","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"2303_CR147","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ijd.12839","volume":"55","author":"Y Xu","year":"2016","unstructured":"Xu, Y., W. Wang, Y. Tian, J. Liu, and R. Yang. 2016. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: A meta-analysis. International Journal of Dermatology 55 (4): 408\u2013416.","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"2303_CR148","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","volume":"71","author":"FD Carmona","year":"2012","unstructured":"Carmona, F.D., R. Gutala, C.P. Simeon, P. Carreira, N. Ortego-Centeno, E. Vicente-Rabaneda, et al. 2012. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. Annals of the Rheumatic Diseases 71 (1): 114\u2013119.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"2303_CR149","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","volume":"17","author":"M Arismendi","year":"2015","unstructured":"Arismendi, M., M. Giraud, N. Ruzehaji, P. Dieude, E. Koumakis, B. Ruiz, et al. 2015. Identification of NF-kappaB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis. Arthritis Research & Therapy 17 (1): 71.","journal-title":"Arthritis Research & Therapy"},{"issue":"7","key":"2303_CR150","doi-asserted-by":"publisher","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","volume":"7","author":"O Gorlova","year":"2011","unstructured":"Gorlova, O., J.E. Martin, B. Rueda, B.P. Koeleman, J. Ying, M. Teruel, et al. 2011. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genetics 7 (7): e1002178.","journal-title":"PLoS Genetics"},{"issue":"3","key":"2303_CR151","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00296-013-2673-8","volume":"34","author":"J Wipff","year":"2014","unstructured":"Wipff, J., P. Dieude, J. Avouac, E. Hachulla, J.L. Cracowski, E. Diot, et al. 2014. Association study of CRP gene in systemic sclerosis in European Caucasian population. Rheumatology International 34 (3): 389\u2013392.","journal-title":"Rheumatology International"},{"issue":"7","key":"2303_CR152","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00420-009-0505-7","volume":"83","author":"ZD McCormic","year":"2010","unstructured":"McCormic, Z.D., S.S. Khuder, B.K. Aryal, A.L. Ames, and S.A. Khuder. 2010. Occupational silica exposure as a risk factor for scleroderma: A meta-analysis. International Archives of Occupational and Environmental Health 83 (7): 763\u2013769.","journal-title":"International Archives of Occupational and Environmental Health"},{"issue":"2 Suppl 76","key":"2303_CR153","first-page":"3","volume":"31","author":"G Moroncini","year":"2013","unstructured":"Moroncini, G., S. Mori, C. Tonnini, and A. Gabrielli. 2013. Role of viral infections in the etiopathogenesis of systemic sclerosis. Clinical and Experimental Rheumatology 31 (2 Suppl 76): 3\u20137.","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"5","key":"2303_CR154","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","volume":"37","author":"I Marie","year":"2015","unstructured":"Marie, I., and J.F. Gehanno. 2015. Environmental risk factors of systemic sclerosis. Semin Immunopathol. 37 (5): 463\u2013473.","journal-title":"Semin Immunopathol."},{"issue":"3","key":"2303_CR155","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ni.1990","volume":"12","author":"T Krausgruber","year":"2011","unstructured":"Krausgruber, T., K. Blazek, T. Smallie, S. Alzabin, H. Lockstone, N. Sahgal, et al. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunology 12 (3): 231\u2013238.","journal-title":"Nature Immunology"},{"key":"2303_CR156","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.12659\/MSM.910756","volume":"24","author":"X Wang","year":"2018","unstructured":"Wang, X., J. Guo, Y. Wang, Y. Xiao, L. Wang, and S. Hua. 2018. Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia. Medical Science Monitor 24: 3620\u20133630.","journal-title":"Medical Science Monitor"},{"key":"2303_CR157","doi-asserted-by":"crossref","unstructured":"Jha M, Wang M, Steele R, Baron M, Fritzler MJ, Canadian Scleroderma Research G, et al. 2022. NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group. Journal of Scleroderma and Related Disorders 7(1):62\u201370","DOI":"10.1177\/23971983211040608"},{"issue":"8","key":"2303_CR158","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/acr.21968","volume":"65","author":"X Liu","year":"2013","unstructured":"Liu, X., M.D. Mayes, C. Pedroza, H.T. Draeger, E.B. Gonzalez, B.E. Harper, et al. 2013. Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis? Arthritis Care Res (Hoboken). 65 (8): 1375\u20131380.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"2","key":"2303_CR159","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1346-8138.2008.00418.x","volume":"35","author":"T Ohtsuka","year":"2008","unstructured":"Ohtsuka, T. 2008. Relation between elevated high-sensitivity C-reactive protein and anti-mitochondria antibody in patients with systemic sclerosis. Journal of Dermatology 35 (2): 70\u201375.","journal-title":"Journal of Dermatology"},{"key":"2303_CR160","doi-asserted-by":"publisher","unstructured":"Muangchan, C., Harding, S., Khimdas, S., Bonner, A., Canadian Scleroderma Research group, Baron, M., & Pope, J. 2012. Association of C-reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group. Arthritis Care & Research 64 (9): 1405\u20131414. https:\/\/doi.org\/10.1002\/acr.21716.","DOI":"10.1002\/acr.21716"},{"issue":"1","key":"2303_CR161","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13075-019-2057-x","volume":"21","author":"A Mitev","year":"2019","unstructured":"Mitev, A., L. Christ, D. Feldmann, M. Binder, K. Moller, A.M. Kanne, et al. 2019. Inflammatory stays inflammatory: A subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide. Arthritis Research & Therapy 21 (1): 262.","journal-title":"Arthritis Research & Therapy"},{"issue":"2","key":"2303_CR162","first-page":"165","volume":"23","author":"Z Nagy","year":"2005","unstructured":"Nagy, Z., and L. Czirjak. 2005. Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis. Clinical and Experimental Rheumatology 23 (2): 165\u2013172.","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"6","key":"2303_CR163","first-page":"30","volume":"78","author":"RT Alekperov","year":"2006","unstructured":"Alekperov, R.T., A.A. Baranov, and N.E. Abaitova. 2006. Clinical associations of C-reactive protein in systemic sclerosis. Terapevticheskii Arkhiv 78 (6): 30\u201335.","journal-title":"Terapevticheskii Arkhiv"},{"issue":"3","key":"2303_CR164","first-page":"514","volume":"31","author":"K Komura","year":"2004","unstructured":"Komura, K., S. Sato, M. Hasegawa, M. Fujimoto, and K. Takehara. 2004. Elevated circulating CD40L concentrations in patients with systemic sclerosis. Journal of Rheumatology 31 (3): 514\u2013519.","journal-title":"Journal of Rheumatology"},{"key":"2303_CR165","doi-asserted-by":"publisher","first-page":"825567","DOI":"10.3389\/fmed.2022.825567","volume":"9","author":"AG Versace","year":"2022","unstructured":"Versace, A.G., A. Bitto, C. Ioppolo, C.O. Aragona, D. La Rosa, W.N. Roberts, et al. 2022. IL-13 and IL-33 Serum levels are increased in systemic sclerosis patients with interstitial lung disease. Frontiers in Medicine (Lausanne) 9: 825567.","journal-title":"Frontiers in Medicine (Lausanne)"},{"issue":"2","key":"2303_CR166","first-page":"183","volume":"45","author":"I Agache","year":"2007","unstructured":"Agache, I., M. Radoi, and L. Duca. 2007. Platelet activation in patients with systemic scleroderma\u2013pattern and significance. Romanian Journal of Internal Medicine 45 (2): 183\u201391.","journal-title":"Romanian Journal of Internal Medicine"},{"issue":"2","key":"2303_CR167","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/03008200903056168","volume":"51","author":"A Olewicz-Gawlik","year":"2010","unstructured":"Olewicz-Gawlik, A., A. Danczak-Pazdrowska, K. Klama, W. Silny, J. Prokop, S. Mackiewicz, et al. 2010. Blood serum levels of amino-terminal pro-C-type natriuretic peptide in patients with systemic sclerosis. Connective Tissue Research 51 (2): 83\u201387.","journal-title":"Connective Tissue Research"},{"issue":"1","key":"2303_CR168","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/ar3694","volume":"14","author":"KE Happonen","year":"2012","unstructured":"Happonen, K.E., T. Saxne, P. Geborek, M. Andersson, A.A. Bengtsson, R. Hesselstrand, et al. 2012. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment. Arthritis Research & Therapy 14 (1): R15.","journal-title":"Arthritis Research & Therapy"},{"issue":"7","key":"2303_CR169","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10067-011-1695-4","volume":"30","author":"F Ogawa","year":"2011","unstructured":"Ogawa, F., K. Shimizu, E. Muroi, T. Hara, and S. Sato. 2011. Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis. Clinical Rheumatology 30 (7): 921\u2013925.","journal-title":"Clinical Rheumatology"},{"issue":"4","key":"2303_CR170","first-page":"659","volume":"26","author":"F Ogawa","year":"2008","unstructured":"Ogawa, F., K. Shimizu, T. Hara, E. Muroi, M. Hasegawa, K. Takehara, et al. 2008. Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: Association with fibrosis and vascular damage. Clinical and Experimental Rheumatology 26 (4): 659\u2013662.","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"5","key":"2303_CR171","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3109\/s10165-012-0755-1","volume":"23","author":"T Takahashi","year":"2013","unstructured":"Takahashi, T., Y. Asano, K. Akamata, N. Aozasa, T. Taniguchi, S. Noda, et al. 2013. Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis. Modern Rheumatology 23 (5): 884\u2013890.","journal-title":"Modern Rheumatology"},{"issue":"3","key":"2303_CR172","first-page":"313","volume":"22","author":"B Frediani","year":"2004","unstructured":"Frediani, B., F. Baldi, P. Falsetti, C. Acciai, G. Filippou, A. Spreafico, et al. 2004. Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clinical and Experimental Rheumatology 22 (3): 313\u2013318.","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"2303_CR173","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/rheumatology\/keh478","volume":"44","author":"I Moyssakis","year":"2005","unstructured":"Moyssakis, I., E. Gialafos, V. Vassiliou, E. Taktikou, C. Katsiari, D.P. Papadopoulos, et al. 2005. Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement. Rheumatology (Oxford) 44 (2): 251\u2013254.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2303_CR174","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/art.22694","volume":"56","author":"GA Tennent","year":"2007","unstructured":"Tennent, G.A., M. Dziadzio, E. Triantafillidou, P. Davies, J.R. Gallimore, C.P. Denton, et al. 2007. Normal circulating serum amyloid P component concentration in systemic sclerosis. Arthritis and Rheumatism 56 (6): 2013\u20132017.","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"2303_CR175","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cyto.2012.02.003","volume":"58","author":"M Tomcik","year":"2012","unstructured":"Tomcik, M., K. Arima, H. Hulejova, M. Kuklova, M. Filkova, M. Braun, et al. 2012. Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis. Cytokine 58 (2): 165\u2013168.","journal-title":"Cytokine"},{"key":"2303_CR176","first-page":"41","volume":"8","author":"EJ Yang","year":"2018","unstructured":"Yang, E.J., K.M. Beck, I.M. Sanchez, J. Koo, and W. Liao. 2018. The impact of genital psoriasis on quality of life: A systematic review. Psoriasis (Auckl). 8: 41\u201347.","journal-title":"Psoriasis (Auckl)."},{"issue":"3","key":"2303_CR177","doi-asserted-by":"publisher","first-page":"173","DOI":"10.12788\/j.sder.2018.045","volume":"37","author":"SA Elman","year":"2018","unstructured":"Elman, S.A., M. Weinblatt, and J.F. Merola. 2018. Targeted therapies for psoriatic arthritis: An update for the dermatologist. Seminars in Cutaneous Medicine and Surgery 37 (3): 173\u2013181.","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"7","key":"2303_CR178","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/ijms20071670","volume":"20","author":"I Lorthois","year":"2019","unstructured":"Lorthois, I., M. Simard, S. Morin, and R. Pouliot. 2019. Infiltration of T cells into a three-dimensional psoriatic skin model mimics pathological key features. International Journal of Molecular Sciences 20 (7): 1670. https:\/\/doi.org\/10.3390\/ijms20071670.","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"2303_CR179","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1346-8138.1992.tb03770.x","volume":"19","author":"KD Cooper","year":"1992","unstructured":"Cooper, K.D. 1992. Skin-infiltrating lymphocytes in normal and disordered skin: Activation signals and functional roles in psoriasis and mycosis fungoides-type cutaneous T cell lymphoma. Journal of Dermatology 19 (11): 731\u2013737.","journal-title":"Journal of Dermatology"},{"issue":"1","key":"2303_CR180","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Y. Chen, L. Cui, Y. Shi, and C. Guo. 2022. Advances in the pathogenesis of psoriasis: From keratinocyte perspective. Cell Death & Disease 13 (1): 81.","journal-title":"Cell Death & Disease"},{"issue":"8","key":"2303_CR181","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong, A.W., M.D. Mehta, C.W. Schupp, G.C. Gondo, S.J. Bell, and C.E.M. Griffiths. 2021. Psoriasis prevalence in adults in the United States. JAMA Dermatology 157 (8): 940\u2013946.","journal-title":"JAMA Dermatology"},{"issue":"1","key":"2303_CR182","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1111\/bjd.15610","volume":"177","author":"CEM Griffiths","year":"2017","unstructured":"Griffiths, C.E.M., J.M. van der Walt, D.M. Ashcroft, C. Flohr, L. Naldi, T. Nijsten, et al. 2017. The global state of psoriasis disease epidemiology: A workshop report. British Journal of Dermatology 177 (1): e4\u2013e7.","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"2303_CR183","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12223-012-0213-7","volume":"58","author":"I Shawkatova","year":"2013","unstructured":"Shawkatova, I., J. Javor, Z. Parnicka, P. Kozub, M. Zilinkova, P. Frey, et al. 2013. HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population. Folia Microbiologia (Praha) 58 (4): 319\u2013324.","journal-title":"Folia Microbiologia (Praha)"},{"issue":"6","key":"2303_CR184","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.clindermatol.2007.08.015","volume":"25","author":"L Fry","year":"2007","unstructured":"Fry, L., and B.S. Baker. 2007. Triggering psoriasis: The role of infections and medications. Clinics in Dermatology 25 (6): 606\u2013615.","journal-title":"Clinics in Dermatology"},{"issue":"5","key":"2303_CR185","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/jid.2009.319","volume":"130","author":"JT Elder","year":"2010","unstructured":"Elder, J.T., A.T. Bruce, J.E. Gudjonsson, A. Johnston, P.E. Stuart, T. Tejasvi, et al. 2010. Molecular dissection of psoriasis: Integrating genetics and biology. The Journal of Investigative Dermatology 130 (5): 1213\u20131226.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"1","key":"2303_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000251595","volume":"148","author":"EM Farber","year":"1974","unstructured":"Farber, E.M., and M.L. Nall. 1974. The natural history of psoriasis in 5,600 patients. Dermatologica 148 (1): 1\u201318.","journal-title":"Dermatologica"},{"issue":"7","key":"2303_CR187","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi, S., P. Guigue, B.R. Renshaw, A. Puel, X.Y. Pei, S. Fraitag, et al. 2011. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. New England Journal of Medicine 365 (7): 620\u2013628.","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"2303_CR188","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","volume":"13","author":"T Henseler","year":"1985","unstructured":"Henseler, T., and E. Christophers. 1985. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology 13 (3): 450\u2013456.","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"2303_CR189","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5114\/reum.2022.120752","volume":"60","author":"W Owczarek","year":"2022","unstructured":"Owczarek, W. 2022. The role of HLA-Cw6 in psoriasis and psoriatic arthritis. Reumatologia 60 (5): 303\u2013305.","journal-title":"Reumatologia"},{"issue":"9997","key":"2303_CR190","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W.H., and M.P. Schon. 2015. Psoriasis. Lancet 386 (9997): 983\u2013994.","journal-title":"Lancet"},{"issue":"7","key":"2303_CR191","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","volume":"181","author":"I Kryczek","year":"2008","unstructured":"Kryczek, I., A.T. Bruce, J.E. Gudjonsson, A. Johnston, A. Aphale, L. Vatan, et al. 2008. Induction of IL-17+ T cell trafficking and development by IFN-gamma: Mechanism and pathological relevance in psoriasis. The Journal of Immunology 181 (7): 4733\u20134741.","journal-title":"The Journal of Immunology"},{"issue":"1","key":"2303_CR192","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin, A.M., C.J. Rubin, R. Khandpur, J.Y. Wang, M. Riblett, S. Yalavarthi, et al. 2011. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. The Journal of Immunology 187 (1): 490\u2013500.","journal-title":"The Journal of Immunology"},{"key":"2303_CR193","first-page":"101","volume":"4","author":"S Kolli","year":"2016","unstructured":"Kolli, S., N. Boda, and E. Reddy. 2016. Ocular menifestation in psoriasis. National Journal Medicine Dental Research 4: 101\u2013104.","journal-title":"National Journal Medicine Dental Research"},{"issue":"4","key":"2303_CR194","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli, E., M. Oukka, and V.K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nature Immunology 8 (4): 345\u2013350.","journal-title":"Nature Immunology"},{"issue":"4","key":"2303_CR195","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms21041275","volume":"21","author":"M Furue","year":"2020","unstructured":"Furue, M., K. Furue, G. Tsuji, and T. Nakahara. 2020. Interleukin-17A and keratinocytes in psoriasis. International Journal of Molecular Sciences 21 (4): 1275. https:\/\/doi.org\/10.3390\/ijms21041275.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"2303_CR196","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.clindermatol.2007.08.016","volume":"25","author":"AS Buchau","year":"2007","unstructured":"Buchau, A.S., and R.L. Gallo. 2007. Innate immunity and antimicrobial defense systems in psoriasis. Clinics in Dermatology 25 (6): 616\u2013624.","journal-title":"Clinics in Dermatology"},{"issue":"6","key":"2303_CR197","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/jid.2008.375","volume":"129","author":"I Teige","year":"2009","unstructured":"Teige, I., H. Hvid, L. Svensson, P.H. Kvist, and K. Kemp. 2009. Regulatory T cells control VEGF-dependent skin inflammation. The Journal of Investigative Dermatology 129 (6): 1437\u20131445.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"3","key":"2303_CR198","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2353\/ajpath.2008.080088","volume":"173","author":"PM Elias","year":"2008","unstructured":"Elias, P.M., J. Arbiser, B.E. Brown, H. Rossiter, M.Q. Man, F. Cerimele, et al. 2008. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia - Implications for the pathogenesis of psoriasis. American Journal of Pathology 173 (3): 689\u2013699.","journal-title":"American Journal of Pathology"},{"issue":"1","key":"2303_CR199","first-page":"140","volume":"16","author":"M El-Domyati","year":"2005","unstructured":"El-Domyati, M., M. Barakat, and R. Abdel-Razek. 2005. Expression of apoptosis regulating proteins, p53 and Bcl-2, in response to Puva therapy for psoriasis. Scientific Journal of El-Minia Faculty of Medicine [The] 16 (1): 140\u2013154.","journal-title":"Scientific Journal of El-Minia Faculty of Medicine [The]"},{"issue":"9","key":"2303_CR200","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.nut.2006.05.011","volume":"22","author":"AB Serwin","year":"2006","unstructured":"Serwin, A.B., W. Wasowicz, and B. Chodynicka. 2006. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B. Nutrition 22 (9): 860\u2013864.","journal-title":"Nutrition"},{"issue":"3","key":"2303_CR201","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12291-011-0132-4","volume":"26","author":"Jain VK Isha","year":"2011","unstructured":"Isha, Jain VK., and H. Lal. 2011. C-reactive protein and uric Acid levels in patients with psoriasis. Indian Journal of Clinical Biochemistry 26 (3): 309\u201311.","journal-title":"Indian Journal of Clinical Biochemistry"},{"issue":"7","key":"2303_CR202","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1468-3083.2009.03527.x","volume":"24","author":"S Coimbra","year":"2010","unstructured":"Coimbra, S., H. Oliveira, F. Reis, L. Belo, S. Rocha, A. Quintanilha, et al. 2010. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. Journal of the European Academy of Dermatology and Venereology 24 (7): 789\u2013796.","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"5","key":"2303_CR203","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1590\/abd1806-4841.20164655","volume":"91","author":"M Farshchian","year":"2016","unstructured":"Farshchian, M., A. Ansar, M. Sobhan, and V. Hoseinpoor. 2016. C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B. Anais Brasileiros de Dermatologia 91 (5): 580\u2013583.","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"6","key":"2303_CR204","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jdv.12257","volume":"28","author":"S Beygi","year":"2014","unstructured":"Beygi, S., V. Lajevardi, and R. Abedini. 2014. C-reactive protein in psoriasis: A review of the literature. Journal of the European Academy of Dermatology and Venereology 28 (6): 700\u2013711.","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"S10","key":"2303_CR205","first-page":"2491","volume":"71","author":"LM \u00d8rnbjerg","year":"2019","unstructured":"\u00d8rnbjerg, L.M., S. Georgiadis, L. Jacobsson, A.G. Loft, F. Iannone, B. Moeller, et al. 2019. Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice-Results from the EuroSpA Collaboration. Arthritis & Rheumatology 71 (S10): 2491.","journal-title":"Arthritis & Rheumatology"},{"key":"2303_CR206","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/annrheumdis-2018-eular.3666","volume":"77","author":"R Scrivo","year":"2018","unstructured":"Scrivo, R., A. Giardino, C. Salvarani, R. Foti, A. Afeltra, O. Viapiana, et al. 2018. THU0329 An italian observational prospective study on predictors of clinical response to golimumab at 6 months in patients with active psoriatic arthritis. Annals of the Rheumatic Diseases 77: 383.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2303_CR207","doi-asserted-by":"publisher","first-page":"7552546","DOI":"10.1155\/2021\/7552546","volume":"2021","author":"L Zeng","year":"2021","unstructured":"Zeng, L., G. Yu, Y. Wu, W. Hao, and H. Chen. 2021. The Effectiveness and Safety of Probiotic Supplements for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Preclinical Trials. Journal of Immunology Research 2021: 7552546.","journal-title":"Journal of Immunology Research"},{"key":"2303_CR208","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2018.00511","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang, L., H.Y. Li, W. Li, Z.Y. Shen, Y.D. Wang, S.R. Ji, et al. 2018. An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma. Frontiers in Immunology 9: 511.","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"2303_CR209","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/0971-4065.120341","volume":"23","author":"V Pradhan","year":"2013","unstructured":"Pradhan, V., A. Rajadhyaksha, K. Yadav, P. Surve, M. Patwardhan, N. Dhavale, et al. 2013. Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus. Indian J Nephrol. 23 (6): 434\u2013437.","journal-title":"Indian J Nephrol."},{"issue":"12","key":"2303_CR210","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.humimm.2008.09.006","volume":"69","author":"Y Tan","year":"2008","unstructured":"Tan, Y., F. Yu, H. Yang, M. Chen, Q. Fang, and M.H. Zhao. 2008. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions. Human Immunology 69 (12): 840\u2013844.","journal-title":"Human Immunology"},{"issue":"2","key":"2303_CR211","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/ar1032","volume":"6","author":"C Sjowall","year":"2004","unstructured":"Sjowall, C., A.A. Bengtsson, G. Sturfelt, and T. Skogh. 2004. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Research & Therapy 6 (2): R87-94.","journal-title":"Arthritis Research & Therapy"},{"key":"2303_CR212","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13075-015-0879-8","volume":"17","author":"SS Pesickova","year":"2015","unstructured":"Pesickova, S.S., R. Rysava, M. Lenicek, L. Vitek, E. Potlukova, Z. Hruskova, et al. 2015. Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up. Arthritis Research & Therapy 17: 371.","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"2303_CR213","doi-asserted-by":"publisher","first-page":"e16236","DOI":"10.15252\/emmm.202216236","volume":"15","author":"J Zeller","year":"2023","unstructured":"Zeller, J., K.S. Cheung Tung Shing, T.L. Nero, J.D. McFadyen, G. Krippner, B. Bogner, et al. 2023. A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein. EMBO Molecular Medicine 15 (1): e16236.","journal-title":"EMBO Molecular Medicine"},{"issue":"6","key":"2303_CR214","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3390\/ijms25063097","volume":"25","author":"Y Pastorello","year":"2024","unstructured":"Pastorello, Y., D. Manu, X. Sawkulycz, V. Caprio, C. Banescu, M. Dobreanu, L. Potempa, M. Di Napoli, and M. Slevin. 2024. mCRP-induced focal adhesion kinase-dependent monocyte aggregation and m1 polarization, which was partially blocked by the C10M inhibitor. International Journal of Molecular Sciences 25 (6): 3097. https:\/\/doi.org\/10.3390\/ijms25063097.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"2303_CR215","first-page":"e60682","volume":"16","author":"Y Pastorello","year":"2024","unstructured":"Pastorello, Y., A.P. Russo, C. B\u0103nescu, V. Caprio, Z. G\u00e1ll, L. Potempa, et al. 2024. Brain vascular expression of monomeric C-reactive protein is blocked by C10M following intraperitoneal injection in an ApoE-\/- murine model of dyslipidemia: an immunohistochemical analysis. Cureus 16 (5): e60682.","journal-title":"Cureus"},{"issue":"1","key":"2303_CR216","doi-asserted-by":"publisher","first-page":"e17003","DOI":"10.15252\/emmm.202217003","volume":"15","author":"JG Filep","year":"2023","unstructured":"Filep, J.G. 2023. Targeting conformational changes in C-reactive protein to inhibit pro-inflammatory actions. EMBO Molecular Medicine 15 (1): e17003.","journal-title":"EMBO Molecular Medicine"},{"key":"2303_CR217","doi-asserted-by":"publisher","first-page":"1264383","DOI":"10.3389\/fimmu.2023.1264383","volume":"14","author":"ME Olson","year":"2023","unstructured":"Olson, M.E., M.G. Hornick, A. Stefanski, H.R. Albanna, A. Gjoni, G.D. Hall, et al. 2023. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: Differentiating pentameric and modified CRP isoform effects. Frontiers in Immunology 14: 1264383.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"2303_CR218","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12872-025-04596-w","volume":"25","author":"D Han","year":"2025","unstructured":"Han, D., L. Wu, H. Zhou, Y. Xue, S. He, Z. Ma, et al. 2025. Associations of the C-reactive protein-albumin-lymphocyte index with all-cause and cardiovascular mortality among individuals with cardiovascular disease: Evidence from the NHANES 2001\u20132010. BMC Cardiovascular Disorders. 25 (1): 144.","journal-title":"BMC Cardiovascular Disorders."},{"issue":"4","key":"2303_CR219","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/CIRCRESAHA.114.302770","volume":"114","author":"T Lane","year":"2014","unstructured":"Lane, T., N. Wassef, S. Poole, Y. Mistry, H.J. Lachmann, J.D. Gillmore, et al. 2014. Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteers. Circulation Research 114 (4): 672\u2013676.","journal-title":"Circulation Research"},{"key":"2303_CR220","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3389\/fimmu.2018.00675","volume":"9","author":"JR Thiele","year":"2018","unstructured":"Thiele, J.R., J. Zeller, J. Kiefer, D. Braig, S. Kreuzaler, Y. Lenz, et al. 2018. A Conformational change in c-reactive protein enhances leukocyte recruitment and reactive oxygen species generation in ischemia\/reperfusion injury. Frontiers in Immunology 9: 675.","journal-title":"Frontiers in Immunology"},{"key":"2303_CR221","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3389\/fimmu.2018.01351","volume":"9","author":"JD McFadyen","year":"2018","unstructured":"McFadyen, J.D., J. Kiefer, D. Braig, J. Loseff-Silver, L.A. Potempa, S.U. Eisenhardt, et al. 2018. Dissociation of C-reactive protein localizes and amplifies inflammation: Evidence for a direct biological role of C-reactive protein and its conformational changes. Frontiers in Immunology 9: 1351.","journal-title":"Frontiers in Immunology"},{"key":"2303_CR222","doi-asserted-by":"publisher","first-page":"102998","DOI":"10.1016\/j.jaut.2023.102998","volume":"135","author":"C Svanberg","year":"2023","unstructured":"Svanberg, C., H. Enocsson, M. Govender, K. Martinsson, L.A. Potempa, I.M. Rajab, et al. 2023. Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation. Journal of Autoimmunity 135: 102998.","journal-title":"Journal of Autoimmunity"},{"issue":"2","key":"2303_CR223","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2478\/jtim-2023-0085","volume":"11","author":"Q Li","year":"2023","unstructured":"Li, Q., C. Liu, and H. Li. 2023. Suggestions on home quarantine and recovery of novel coronavirus patients. Journal of Translational Internal Medicine. 11 (2): 111\u2013114.","journal-title":"Journal of Translational Internal Medicine."},{"issue":"1","key":"2303_CR224","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smhs.2019.08.006","volume":"1","author":"E Anderson","year":"2019","unstructured":"Anderson, E., and J.L. Durstine. 2019. Physical activity, exercise, and chronic diseases: A brief review. Sports Medicine and Health Science. 1 (1): 3\u201310.","journal-title":"Sports Medicine and Health Science."},{"key":"2303_CR225","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejim.2023.05.036","volume":"114","author":"A Farsetti","year":"2023","unstructured":"Farsetti, A., B. Illi, and C. Gaetano. 2023. How epigenetics impacts on human diseases. European Journal of Internal Medicine. 114: 15\u201322.","journal-title":"European Journal of Internal Medicine."},{"issue":"6","key":"2303_CR226","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1096\/fj.08-116962","volume":"23","author":"SR Ji","year":"2009","unstructured":"Ji, S.R., L. Ma, C.J. Bai, J.M. Shi, H.Y. Li, L.A. Potempa, et al. 2009. Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. The FASEB Journal 23 (6): 1806\u20131816.","journal-title":"The FASEB Journal"},{"issue":"1","key":"2303_CR227","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s42003-022-03220-3","volume":"5","author":"B Cheng","year":"2022","unstructured":"Cheng, B., J.M. Lv, Y.L. Liang, L. Zhu, X.P. Huang, H.Y. Li, et al. 2022. Secretory quality control constrains functional selection-associated protein structure innovation. Communications Biology 5 (1): 268.","journal-title":"Communications Biology"},{"issue":"7088","key":"2303_CR228","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nature04672","volume":"440","author":"MB Pepys","year":"2006","unstructured":"Pepys, M.B., G.M. Hirschfield, G.A. Tennent, J.R. Gallimore, M.C. Kahan, V. Bellotti, et al. 2006. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 (7088): 1217\u20131221.","journal-title":"Nature"},{"issue":"3","key":"2303_CR229","first-page":"152","volume":"10","author":"Q Li","year":"2024","unstructured":"Li, Q., L. Li, and Y. Li. 2024. Developing ChatGPT for biology and medicine: A complete review of biomedical question answering. Biophysics Reports 10 (3): 152\u2013171.","journal-title":"Biophysics Reports"},{"issue":"3","key":"2303_CR230","first-page":"135","volume":"10","author":"Y Si","year":"2024","unstructured":"Si, Y., J. Zou, Y. Gao, G. Chuai, Q. Liu, and L. Chen. 2024. Foundation models in molecular biology. Biophysics Reports 10 (3): 135\u2013151.","journal-title":"Biophysics Reports"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02303-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02303-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02303-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T01:03:11Z","timestamp":1766451791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02303-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":230,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2303"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02303-7","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}